203 related articles for article (PubMed ID: 16960684)
1. Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids.
Brunmair B; Staniek K; Dörig J; Szöcs Z; Stadlbauer K; Marian V; Gras F; Anderwald C; Nohl H; Waldhäusl W; Fürnsinn C
Diabetologia; 2006 Nov; 49(11):2713-22. PubMed ID: 16960684
[TBL] [Abstract][Full Text] [Related]
2. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
[TBL] [Abstract][Full Text] [Related]
3. PPARδ activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preference.
Feng YZ; Nikolić N; Bakke SS; Boekschoten MV; Kersten S; Kase ET; Rustan AC; Thoresen GH
Arch Physiol Biochem; 2014 Feb; 120(1):12-21. PubMed ID: 23991827
[TBL] [Abstract][Full Text] [Related]
4. The PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells.
Dimopoulos N; Watson M; Green C; Hundal HS
FEBS Lett; 2007 Oct; 581(24):4743-8. PubMed ID: 17869249
[TBL] [Abstract][Full Text] [Related]
5. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.
Al-Khalili L; Bouzakri K; Glund S; Lönnqvist F; Koistinen HA; Krook A
Mol Endocrinol; 2006 Dec; 20(12):3364-75. PubMed ID: 16945991
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of a PPAR-delta agonist to rodents worsens, not improves, maximal insulin-stimulated glucose transport in skeletal muscle of different fibers.
Cresser J; Bonen A; Chabowski A; Stefanyk LE; Gulli R; Ritchie I; Dyck DJ
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R470-9. PubMed ID: 20538899
[TBL] [Abstract][Full Text] [Related]
7. PPARdelta activator GW-501516 has no acute effect on glucose transport in skeletal muscle.
Terada S; Wicke S; Holloszy JO; Han DH
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E607-11. PubMed ID: 16278250
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.
Risérus U; Sprecher D; Johnson T; Olson E; Hirschberg S; Liu A; Fang Z; Hegde P; Richards D; Sarov-Blat L; Strum JC; Basu S; Cheeseman J; Fielding BA; Humphreys SM; Danoff T; Moore NR; Murgatroyd P; O'Rahilly S; Sutton P; Willson T; Hassall D; Frayn KN; Karpe F
Diabetes; 2008 Feb; 57(2):332-9. PubMed ID: 18024853
[TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
10. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.
Krämer DK; Al-Khalili L; Guigas B; Leng Y; Garcia-Roves PM; Krook A
J Biol Chem; 2007 Jul; 282(27):19313-20. PubMed ID: 17500064
[TBL] [Abstract][Full Text] [Related]
11. Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model.
Li X; Li J; Lu X; Ma H; Shi H; Li H; Xie D; Dong L; Liang C
Int J Mol Med; 2015 Sep; 36(3):767-75. PubMed ID: 26133486
[TBL] [Abstract][Full Text] [Related]
12. Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study.
Jucker BM; Yang D; Casey WM; Olzinski AR; Williams C; Lenhard SC; Legos JJ; Hawk CT; Sarkar SK; Newsholme SJ
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1256-64. PubMed ID: 17726146
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes.
Robciuc MR; Skrobuk P; Anisimov A; Olkkonen VM; Alitalo K; Eckel RH; Koistinen HA; Jauhiainen M; Ehnholm C
PLoS One; 2012; 7(10):e46212. PubMed ID: 23056264
[TBL] [Abstract][Full Text] [Related]
14. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta.
Muoio DM; MacLean PS; Lang DB; Li S; Houmard JA; Way JM; Winegar DA; Corton JC; Dohm GL; Kraus WE
J Biol Chem; 2002 Jul; 277(29):26089-97. PubMed ID: 12118038
[TBL] [Abstract][Full Text] [Related]
16. The effects of amino acids on glucose metabolism of isolated rat skeletal muscle are independent of insulin and the mTOR/S6K pathway.
Stadlbauer K; Brunmair B; Szöcs Z; Krebs M; Luger A; Fürnsinn C
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E785-92. PubMed ID: 19622787
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-δ activates endothelial progenitor cells to induce angio-myogenesis through matrix metallo-proteinase-9-mediated insulin-like growth factor-1 paracrine networks.
Han JK; Kim HL; Jeon KH; Choi YE; Lee HS; Kwon YW; Jang JJ; Cho HJ; Kang HJ; Oh BH; Park YB; Kim HS
Eur Heart J; 2013 Jun; 34(23):1755-65. PubMed ID: 21920965
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-delta, a regulator of oxidative capacity, fuel switching and cholesterol transport.
Fürnsinn C; Willson TM; Brunmair B
Diabetologia; 2007 Jan; 50(1):8-17. PubMed ID: 17119917
[TBL] [Abstract][Full Text] [Related]
19. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta.
Krämer DK; Al-Khalili L; Perrini S; Skogsberg J; Wretenberg P; Kannisto K; Wallberg-Henriksson H; Ehrenborg E; Zierath JR; Krook A
Diabetes; 2005 Apr; 54(4):1157-63. PubMed ID: 15793256
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.
Chen W; Wang LL; Liu HY; Long L; Li S
Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):240-6. PubMed ID: 18684227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
